25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

7081 (Pharmaniaga) Stock Analysis
Buy, Hold or Sell?

Let's analyze Pharmaniaga together

I guess you are interested in Pharmaniaga Bhd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Pharmaniagaโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Pharmaniagaโ€™s Price Targets

I'm going to help you getting a better view of Pharmaniaga Bhd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Pharmaniaga Bhd

I send you an email if I find something interesting about Pharmaniaga Bhd.

1. Quick Overview

1.1. Quick analysis of Pharmaniaga (30 sec.)










1.2. What can you expect buying and holding a share of Pharmaniaga? (30 sec.)

How much money do you get?

How much money do you get?
RM0.00
When do you have the money?
1 year
How often do you get paid?
51.7%

What is your share worth?

Current worth
RM-0.08
Expected worth in 1 year
RM0.01
How sure are you?
72.4%

+ What do you gain per year?

Total Gains per Share
RM0.09
Return On Investment
53.4%

For what price can you sell your share?

Current Price per Share
RM0.17
Expected price per share
RM0.1277847826087 - RM0.18725538461539
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pharmaniaga (5 min.)




Live pricePrice per Share (EOD)
RM0.17
Intrinsic Value Per Share
RM0.64 - RM0.79
Total Value Per Share
RM0.56 - RM0.71

2.2. Growth of Pharmaniaga (5 min.)




Is Pharmaniaga growing?

Current yearPrevious yearGrowGrow %
How rich?-$28m-$51.2m$12.3m31.6%

How much money is Pharmaniaga making?

Current yearPrevious yearGrowGrow %
Making money$7.9m-$3.3m$11.3m142.1%
Net Profit Margin3.3%-1.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Pharmaniaga (5 min.)




2.4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pharmaniaga?

Welcome investor! Pharmaniaga's management wants to use your money to grow the business. In return you get a share of Pharmaniaga.

First you should know what it really means to hold a share of Pharmaniaga. And how you can make/lose money.

Speculation

The Price per Share of Pharmaniaga is RM0.165. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmaniaga.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmaniaga, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is RM-0.08. Based on the TTM, the Book Value Change Per Share is RM0.02 per quarter. Based on the YOY, the Book Value Change Per Share is RM-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is RM0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmaniaga.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 RM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per Share
Usd Eps0.002.9%0.013.4%0.00-1.4%-0.01-4.6%0.00-1.7%0.00-1.4%
Usd Book Value Change Per Share0.002.7%0.013.1%-0.01-3.1%-0.01-4.4%0.00-2.3%0.00-0.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.7%0.001.2%0.001.1%
Usd Total Gains Per Share0.002.7%0.013.1%-0.01-3.1%-0.01-3.7%0.00-1.1%0.000.7%
Usd Price Per Share0.06-0.08-0.09-0.09-0.32-0.52-
Price to Earnings Ratio2.86-26.60-16.47-45.23-81.33-143.40-
Price-to-Total Gains Ratio12.61--74.30-20.60--14.97-223.02-201.39-
Price to Book Ratio-2.84--3.06--2.86--2.13-3.26-5.75-
Price-to-Total Gains Ratio12.61--74.30-20.60--14.97-223.02-201.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0388245
Number of shares25756
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (25756 shares)133.59-47.69
Gains per Year (25756 shares)534.35-190.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10534524204-394-201
2010691058407-789-392
3016031592611-1183-583
4021372126815-1578-774
50267226601019-1972-965
60320631941222-2367-1156
70374037281426-2761-1347
80427542621630-3156-1538
90480947961834-3550-1729
100534353302037-3945-1920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.03.00.075.0%16.04.00.080.0%24.05.00.082.8%24.05.00.082.8%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%12.08.00.060.0%16.013.00.055.2%16.013.00.055.2%
Dividend per Share0.00.04.00.0%6.00.06.050.0%12.00.08.060.0%15.00.014.051.7%15.00.014.051.7%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%15.05.00.075.0%21.08.00.072.4%21.08.00.072.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Pharmaniaga Bhd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0190.022-15%-0.022+218%-0.031+265%-0.016+187%-0.003+115%
Book Value Per Share---0.083-0.115+39%-0.151+83%-0.067-19%0.064-229%0.152-154%
Current Ratio--0.6450.620+4%0.608+6%0.692-7%0.786-18%0.804-20%
Debt To Asset Ratio--1.0561.079-2%1.110-5%1.055+0%0.960+10%0.878+20%
Debt To Equity Ratio----0%-0%0.846-100%2.326-100%2.142-100%
Dividend Per Share----0%0.000-100%0.005-100%0.008-100%0.008-100%
Enterprise Value---1919598961.280-1697223891.200-12%-1593845431.040-17%-1564186848.507-19%15739823.238-12296%1473762299.172-230%
Eps--0.0210.024-13%-0.010+148%-0.032+256%-0.012+159%-0.010+147%
Ev To Sales Ratio---0.455-0.443-3%-0.458+1%-0.437-4%0.069-759%0.674-167%
Free Cash Flow Per Share--0.0120.015-16%-0.003+128%-0.012+194%-0.010+182%-0.013+202%
Free Cash Flow To Equity Per Share--0.0120.014-15%0.004+188%0.008+54%0.044-72%0.042-71%
Gross Profit Margin--1.0001.0000%1.981-50%1.334-25%1.201-17%1.138-12%
Intrinsic Value_10Y_max--0.792----------
Intrinsic Value_10Y_min--0.641----------
Intrinsic Value_1Y_max---0.028----------
Intrinsic Value_1Y_min---0.028----------
Intrinsic Value_3Y_max---0.002----------
Intrinsic Value_3Y_min---0.004----------
Intrinsic Value_5Y_max--0.122----------
Intrinsic Value_5Y_min--0.106----------
Market Cap237802942.080-42%338689038.720486415108.800-30%556675068.960-39%580695568.160-42%1964043323.238-83%3174453092.275-89%
Net Profit Margin--0.0280.033-15%-0.018+164%-0.058+308%-0.024+185%-0.018+166%
Operating Margin---0.044-100%0.002-100%0.014-100%0.011-100%0.006-100%
Operating Ratio--1.8231.192+53%0.998+83%1.195+53%1.448+26%1.521+20%
Pb Ratio-1.997+30%-2.844-3.062+8%-2.863+1%-2.132-25%3.263-187%5.750-149%
Pe Ratio2.010-42%2.86326.604-89%16.469-83%45.235-94%81.333-96%143.404-98%
Price Per Share0.165-42%0.2350.338-30%0.386-39%0.403-42%1.363-83%2.203-89%
Price To Free Cash Flow Ratio3.349-42%4.769-4.759+200%-6.043+227%-2.928+161%-17.617+469%-12.329+358%
Price To Total Gains Ratio8.855-42%12.612-74.304+689%20.601-39%-14.967+219%223.021-94%201.391-94%
Quick Ratio--0.2900.302-4%0.287+1%0.286+1%0.309-6%0.310-7%
Return On Assets--0.0140.016-13%-0.008+155%-0.027+293%-0.011+183%-0.009+166%
Return On Equity----0%-0%-0.0030%0.023-100%0.002-100%
Total Gains Per Share--0.0190.022-15%-0.022+218%-0.026+237%-0.008+142%0.005+270%
Usd Book Value---28021877.000-38976680.275+39%-51292929.350+83%-22780334.200-19%21772003.110-229%51452134.141-154%
Usd Book Value Change Per Share--0.0040.005-15%-0.005+218%-0.007+265%-0.004+187%-0.001+115%
Usd Book Value Per Share---0.019-0.027+39%-0.036+83%-0.016-19%0.015-229%0.036-154%
Usd Dividend Per Share----0%0.000-100%0.001-100%0.002-100%0.002-100%
Usd Enterprise Value---451681635.589-399356781.599-12%-375031829.924-17%-368053165.454-19%3703580.408-12296%346776268.995-230%
Usd Eps--0.0050.006-13%-0.002+148%-0.008+256%-0.003+159%-0.002+147%
Usd Free Cash Flow--4177280.9004989065.900-16%-1181911.900+128%-3918862.675+194%-3445580.255+182%-3086941.269+174%
Usd Free Cash Flow Per Share--0.0030.003-16%-0.001+128%-0.003+194%-0.002+182%-0.003+202%
Usd Free Cash Flow To Equity Per Share--0.0030.003-15%0.001+188%0.002+54%0.010-72%0.010-71%
Usd Market Cap55955032.271-42%79693530.811114453475.101-30%130985643.726-39%136637667.188-42%462139393.958-83%746948812.612-89%
Usd Price Per Share0.039-42%0.0550.079-30%0.091-39%0.095-42%0.321-83%0.518-89%
Usd Profit--6959938.7007985787.875-13%-3362495.825+148%-11302498.242+262%-4369979.835+163%-3474804.921+150%
Usd Revenue--248323619.700226468543.925+10%205239601.450+21%210555655.917+18%216716111.885+15%197464246.828+26%
Usd Total Gains Per Share--0.0040.005-15%-0.005+218%-0.006+237%-0.002+142%0.001+270%
 EOD+3 -5MRQTTM+9 -25YOY+24 -133Y+21 -175Y+17 -2210Y+17 -22

3.3 Fundamental Score

Let's check the fundamental score of Pharmaniaga Bhd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152.010
Price to Book Ratio (EOD)Between0-1-1.997
Net Profit Margin (MRQ)Greater than00.028
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.290
Current Ratio (MRQ)Greater than10.645
Debt to Asset Ratio (MRQ)Less than11.056
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.014
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Pharmaniaga Bhd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.345
Ma 20Greater thanMa 500.145
Ma 50Greater thanMa 1000.153
Ma 100Greater thanMa 2000.148
OpenGreater thanClose0.155
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Pharmaniaga Bhd

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and installation of medical and hospital equipment. The company also manufactures and sells generic drugs; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and develops pharmacy management system for ordering management system, point-of-sale transactions, and inventory management. The company was founded in 1994 and is based in Shah Alam, Malaysia.

Fundamental data was last updated by Penke on 2025-06-28 07:38:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Pharmaniaga earns for each RM1 of revenue.

  • Above 10% is considered healthy but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A Net Profit Margin of 2.8%ย means thatย RM0.03 for each RM1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharmaniaga Bhd:

  • The MRQ is 2.8%. The company is making a profit. +1
  • The TTM is 3.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM3.3%-0.5%
TTM3.3%YOY-1.8%+5.1%
TTM3.3%5Y-2.4%+5.7%
5Y-2.4%10Y-1.8%-0.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8%1.8%+1.0%
TTM3.3%1.3%+2.0%
YOY-1.8%1.5%-3.3%
3Y-5.8%1.9%-7.7%
5Y-2.4%2.0%-4.4%
10Y-1.8%2.1%-3.9%
4.3.1.2. Return on Assets

Shows howย efficientย Pharmaniaga is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • 1.4% Return on Assets means thatย Pharmaniaga generatedย RM0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharmaniaga Bhd:

  • The MRQ is 1.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.4%TTM1.6%-0.2%
TTM1.6%YOY-0.8%+2.3%
TTM1.6%5Y-1.1%+2.7%
5Y-1.1%10Y-0.9%-0.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4%0.7%+0.7%
TTM1.6%0.7%+0.9%
YOY-0.8%0.9%-1.7%
3Y-2.7%0.9%-3.6%
5Y-1.1%0.9%-2.0%
10Y-0.9%0.9%-1.8%
4.3.1.3. Return on Equity

Shows how efficient Pharmaniaga is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • 0.0% Return on Equity means Pharmaniaga generated RM0.00ย for eachย RM1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharmaniaga Bhd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.3%-2.3%
5Y2.3%10Y0.2%+2.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.8%-1.8%
TTM-1.6%-1.6%
YOY-2.4%-2.4%
3Y-0.3%1.9%-2.2%
5Y2.3%2.1%+0.2%
10Y0.2%2.7%-2.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Pharmaniaga Bhd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Pharmaniaga is operatingย .

  • Measures how much profit Pharmaniaga makes for each RM1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • An Operating Margin of 0.0%ย means the company generated RM0.00 ย for each RM1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharmaniaga Bhd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.4%-4.4%
TTM4.4%YOY0.2%+4.2%
TTM4.4%5Y1.1%+3.3%
5Y1.1%10Y0.6%+0.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-2.9%
TTM4.4%2.0%+2.4%
YOY0.2%2.8%-2.6%
3Y1.4%2.8%-1.4%
5Y1.1%3.1%-2.0%
10Y0.6%2.9%-2.3%
4.3.2.2. Operating Ratio

Measures how efficient Pharmaniaga is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Medical Distribution industry mean).
  • An Operation Ratio of 1.82 means that the operating costs are RM1.82 for each RM1 in net sales.

Let's take a look of the Operating Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 1.823. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.192. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.823TTM1.192+0.631
TTM1.192YOY0.998+0.194
TTM1.1925Y1.448-0.256
5Y1.44810Y1.521-0.074
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8231.667+0.156
TTM1.1921.432-0.240
YOY0.9980.987+0.011
3Y1.1951.206-0.011
5Y1.4481.102+0.346
10Y1.5211.055+0.466
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Pharmaniaga Bhd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pharmaniaga is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Medical Distribution industry mean).
  • A Current Ratio of 0.65ย means the company has RM0.65 in assets for each RM1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.645. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.620. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.645TTM0.620+0.025
TTM0.620YOY0.608+0.012
TTM0.6205Y0.786-0.166
5Y0.78610Y0.804-0.018
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6451.355-0.710
TTM0.6201.347-0.727
YOY0.6081.367-0.759
3Y0.6921.371-0.679
5Y0.7861.356-0.570
10Y0.8041.348-0.544
4.4.3.2. Quick Ratio

Measures if Pharmaniaga is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A Quick Ratio of 0.29ย means the company can pay off RM0.29 for each RM1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.290. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.302. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.290TTM0.302-0.012
TTM0.302YOY0.287+0.015
TTM0.3025Y0.309-0.007
5Y0.30910Y0.310-0.002
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2900.640-0.350
TTM0.3020.726-0.424
YOY0.2870.812-0.525
3Y0.2860.817-0.531
5Y0.3090.842-0.533
10Y0.3100.903-0.593
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Pharmaniaga Bhd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Pharmaniagaย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Pharmaniaga to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 1.06ย means that Pharmaniaga assets areย financed with 105.6% credit (debt) and the remaining percentage (100% - 105.6%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 1.056. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.079. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.056TTM1.079-0.024
TTM1.079YOY1.110-0.030
TTM1.0795Y0.960+0.120
5Y0.96010Y0.878+0.082
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0560.616+0.440
TTM1.0790.625+0.454
YOY1.1100.588+0.522
3Y1.0550.599+0.456
5Y0.9600.597+0.363
10Y0.8780.596+0.282
4.5.4.2. Debt to Equity Ratio

Measures ifย Pharmaniaga is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A Debt to Equity ratio of 0.0% means that company has RM0.00 debt for each RM1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.326-2.326
5Y2.32610Y2.142+0.184
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.740-1.740
TTM-1.743-1.743
YOY-1.474-1.474
3Y0.8461.763-0.917
5Y2.3261.687+0.639
10Y2.1421.796+0.346
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every RM1 in earnings Pharmaniaga generates.

  • Above 15 is considered overpriced butย always compareย Pharmaniaga to theย Medical Distribution industry mean.
  • A PE ratio of 2.86 means the investor is paying RM2.86ย for every RM1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharmaniaga Bhd:

  • The EOD is 2.010. Based on the earnings, the company is cheap. +2
  • The MRQ is 2.863. Based on the earnings, the company is cheap. +2
  • The TTM is 26.604. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.010MRQ2.863-0.853
MRQ2.863TTM26.604-23.741
TTM26.604YOY16.469+10.134
TTM26.6045Y81.333-54.729
5Y81.33310Y143.404-62.072
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD2.01012.945-10.935
MRQ2.86311.175-8.312
TTM26.60410.216+16.388
YOY16.46919.708-3.239
3Y45.23515.790+29.445
5Y81.33316.456+64.877
10Y143.40416.560+126.844
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharmaniaga Bhd:

  • The EOD is 3.349. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.769. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -4.759. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.349MRQ4.769-1.421
MRQ4.769TTM-4.759+9.528
TTM-4.759YOY-6.043+1.285
TTM-4.7595Y-17.617+12.859
5Y-17.61710Y-12.329-5.289
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD3.3492.990+0.359
MRQ4.7692.836+1.933
TTM-4.7596.749-11.508
YOY-6.0433.943-9.986
3Y-2.9283.573-6.501
5Y-17.6173.661-21.278
10Y-12.3295.453-17.782
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Pharmaniaga is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Medical Distribution industry mean).
  • A PB ratio of -2.84 means the investor is paying RM-2.84ย for each RM1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharmaniaga Bhd:

  • The EOD is -1.997. Based on the equity, the company is expensive. -2
  • The MRQ is -2.844. Based on the equity, the company is expensive. -2
  • The TTM is -3.062. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.997MRQ-2.844+0.847
MRQ-2.844TTM-3.062+0.218
TTM-3.062YOY-2.863-0.199
TTM-3.0625Y3.263-6.325
5Y3.26310Y5.750-2.487
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-1.9970.914-2.911
MRQ-2.8440.995-3.839
TTM-3.0620.959-4.021
YOY-2.8631.182-4.045
3Y-2.1321.183-3.315
5Y3.2631.307+1.956
10Y5.7501.675+4.075
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in MYR. All numbers in thousands.

Summary
Total Assets2,139,198
Total Liabilities2,258,288
Total Stockholder Equity-144,078
 As reported
Total Liabilities 2,258,288
Total Stockholder Equity+ -144,078
Total Assets = 2,139,198

Assets

Total Assets2,139,198
Total Current Assets1,357,753
Long-term Assets781,445
Total Current Assets
Cash And Cash Equivalents 138,190
Net Receivables 609,734
Inventory 583,842
Total Current Assets  (as reported)1,357,753
Total Current Assets  (calculated)1,331,766
+/- 25,987
Long-term Assets
Property Plant Equipment 604,196
Goodwill 75,128
Intangible Assets 75,203
Long-term Assets  (as reported)781,445
Long-term Assets  (calculated)754,527
+/- 26,918

Liabilities & Shareholders' Equity

Total Current Liabilities2,104,400
Long-term Liabilities153,888
Total Stockholder Equity-144,078
Total Current Liabilities
Short Long Term Debt 1,048,554
Accounts payable 955,660
Total Current Liabilities  (as reported)2,104,400
Total Current Liabilities  (calculated)2,004,214
+/- 100,186
Long-term Liabilities
Long term Debt 99,318
Capital Lease Obligations Min Short Term Debt6,190
Long-term Liabilities  (as reported)153,888
Long-term Liabilities  (calculated)105,508
+/- 48,380
Total Stockholder Equity
Total Stockholder Equity (as reported)-144,078
Total Stockholder Equity (calculated)0
+/- 144,078
Other
Capital Stock200,046
Common Stock Shares Outstanding 1,441,230
Net Debt 1,009,682
Net Invested Capital 1,003,794
Net Working Capital -746,647
Property Plant and Equipment Gross 604,196



6.2. Balance Sheets Structured

Currency in MYR. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312016-03-312015-12-312015-09-302015-06-30
> Total Assets 
1,427,000
1,474,000
1,496,000
1,574,000
1,905,136
1,917,879
1,944,461
1,592,302
1,699,415
1,813,208
1,765,665
1,580,157
1,905,658
2,547,892
2,382,710
2,257,863
2,467,583
2,440,944
2,551,246
1,847,291
2,121,509
2,062,093
1,961,577
1,914,854
2,064,143
2,079,595
2,146,266
1,992,306
2,139,198
2,139,1981,992,3062,146,2662,079,5952,064,1431,914,8541,961,5772,062,0932,121,5091,847,2912,551,2462,440,9442,467,5832,257,8632,382,7102,547,8921,905,6581,580,1571,765,6651,813,2081,699,4151,592,3021,944,4611,917,8791,905,1361,574,0001,496,0001,474,0001,427,000
   > Total Current Assets 
782,000
792,000
769,000
831,000
1,048,790
1,062,547
1,084,253
933,711
1,054,222
1,161,047
1,125,903
926,244
1,247,948
1,882,528
1,720,692
1,621,194
1,828,190
1,776,254
1,866,070
1,194,806
1,356,900
1,295,878
1,161,971
1,107,466
1,261,113
1,272,946
1,340,901
1,204,291
1,357,753
1,357,7531,204,2911,340,9011,272,9461,261,1131,107,4661,161,9711,295,8781,356,9001,194,8061,866,0701,776,2541,828,1901,621,1941,720,6921,882,5281,247,948926,2441,125,9031,161,0471,054,222933,7111,084,2531,062,5471,048,790831,000769,000792,000782,000
       Cash And Cash Equivalents 
16,000
18,000
23,000
28,000
0
0
39,423
29,587
34,230
32,718
36,540
40,696
62,781
65,501
53,776
52,359
136,542
39,887
28,069
52,849
56,621
27,774
30,726
127,441
86,602
66,765
66,428
152,203
138,190
138,190152,20366,42866,76586,602127,44130,72627,77456,62152,84928,06939,887136,54252,35953,77665,50162,78140,69636,54032,71834,23029,58739,4230028,00023,00018,00016,000
       Short-term Investments 
0
0
3,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,726
4,110
0
0
0
2,865
0
6,496
0
0
0
0006,49602,8650004,1104,7260000000000000003,00000
       Net Receivables 
249,000
281,000
182,000
285,000
426,312
414,428
465,548
204,100
506,766
485,112
457,346
237,411
544,839
822,720
522,672
297,722
456,266
455,263
509,203
261,751
552,362
583,131
546,593
285,220
592,070
578,927
637,043
407,513
609,734
609,734407,513637,043578,927592,070285,220546,593583,131552,362261,751509,203455,263456,266297,722522,672822,720544,839237,411457,346485,112506,766204,100465,548414,428426,312285,000182,000281,000249,000
       Inventory 
517,000
492,000
540,000
518,000
558,891
589,539
562,436
617,909
511,961
640,745
629,370
586,713
630,411
984,078
1,135,896
1,264,369
1,225,068
1,267,833
1,304,113
767,263
732,513
672,991
566,315
580,643
550,944
595,950
620,345
612,793
583,842
583,842612,793620,345595,950550,944580,643566,315672,991732,513767,2631,304,1131,267,8331,225,0681,264,3691,135,896984,078630,411586,713629,370640,745511,961617,909562,436589,539558,891518,000540,000492,000517,000
   > Long-term Assets 
0
0
0
0
0
0
860,208
658,591
645,193
652,161
639,762
653,913
657,710
665,364
662,018
636,669
639,393
664,690
685,176
652,485
764,609
766,215
799,606
807,388
803,030
806,649
805,365
788,015
781,445
781,445788,015805,365806,649803,030807,388799,606766,215764,609652,485685,176664,690639,393636,669662,018665,364657,710653,913639,762652,161645,193658,591860,208000000
       Property Plant Equipment 
0
0
0
0
421,134
419,563
417,694
410,110
403,265
402,199
395,063
398,471
399,704
407,077
399,810
395,590
397,289
421,131
434,495
443,034
576,239
576,349
577,487
605,748
604,041
603,228
603,647
609,355
604,196
604,196609,355603,647603,228604,041605,748577,487576,349576,239443,034434,495421,131397,289395,590399,810407,077399,704398,471395,063402,199403,265410,110417,694419,563421,1340000
       Goodwill 
127,000
130,000
133,000
130,000
131,292
132,410
132,783
132,783
127,004
133,715
129,800
131,105
130,919
131,105
133,601
129,475
129,661
130,221
131,712
77,341
77,447
77,577
77,517
77,468
77,468
77,387
75,161
77,305
75,128
75,12877,30575,16177,38777,46877,46877,51777,57777,44777,341131,712130,221129,661129,475133,601131,105130,919131,105129,800133,715127,004132,783132,783132,410131,292130,000133,000130,000127,000
       Intangible Assets 
0
0
0
0
265,824
266,057
269,596
67,559
66,808
72,193
71,598
73,932
76,083
77,737
72,924
78,538
80,258
81,257
85,292
72,393
84,340
86,571
76,197
72,090
71,791
16,037
74,913
74,012
75,203
75,20374,01274,91316,03771,79172,09076,19786,57184,34072,39385,29281,25780,25878,53872,92477,73776,08373,93271,59872,19366,80867,559269,596266,057265,8240000
       Other Assets 
0
0
0
0
38,096
37,302
40,135
48,139
48,116
44,054
43,301
50,405
51,004
49,445
55,683
33,066
32,185
32,081
33,677
88,459
26,583
90,930
0
0
0
0
0
0
0
000000090,93026,58388,45933,67732,08132,18533,06655,68349,44551,00450,40543,30144,05448,11648,13940,13537,30238,0960000
> Total Liabilities 
873,000
911,000
936,000
1,033,000
1,376,163
1,397,104
1,409,292
1,254,451
1,349,440
1,455,186
1,420,106
1,242,629
1,548,935
2,189,828
1,990,870
1,807,401
2,053,439
2,034,440
2,117,475
2,195,599
2,240,699
2,175,023
2,200,351
2,188,944
2,310,307
2,326,980
2,296,434
2,138,250
2,258,288
2,258,2882,138,2502,296,4342,326,9802,310,3072,188,9442,200,3512,175,0232,240,6992,195,5992,117,4752,034,4402,053,4391,807,4011,990,8702,189,8281,548,9351,242,6291,420,1061,455,1861,349,4401,254,4511,409,2921,397,1041,376,1631,033,000936,000911,000873,000
   > Total Current Liabilities 
839,000
874,000
894,000
989,000
1,272,960
1,292,472
1,323,445
1,200,581
1,300,295
1,402,510
1,370,804
1,193,819
1,497,322
2,023,244
1,636,639
1,467,763
1,698,220
1,672,854
1,766,156
2,067,710
1,953,425
1,892,458
1,923,585
2,002,447
2,137,724
2,154,959
2,138,140
1,953,073
2,104,400
2,104,4001,953,0732,138,1402,154,9592,137,7242,002,4471,923,5851,892,4581,953,4252,067,7101,766,1561,672,8541,698,2201,467,7631,636,6392,023,2441,497,3221,193,8191,370,8041,402,5101,300,2951,200,5811,323,4451,292,4721,272,960989,000894,000874,000839,000
       Short-term Debt 
430,000
505,000
400,000
598,000
0
0
0
564,616
640,025
676,631
728,847
668,837
534,515
811,560
484,942
543,979
525,048
610,745
782,132
1,071,427
1,035,736
919,851
922,408
1,051,670
1,089,070
1,081,091
1,123,010
1,059,147
0
01,059,1471,123,0101,081,0911,089,0701,051,670922,408919,8511,035,7361,071,427782,132610,745525,048543,979484,942811,560534,515668,837728,847676,631640,025564,616000598,000400,000505,000430,000
       Short Long Term Debt 
430,000
505,000
400,000
598,000
0
0
709,346
564,616
640,025
676,631
728,847
668,837
789,515
1,007,560
516,242
569,679
653,648
781,353
776,502
967,753
1,029,857
914,059
916,628
1,047,050
1,085,616
1,078,887
1,119,455
1,054,669
1,048,554
1,048,5541,054,6691,119,4551,078,8871,085,6161,047,050916,628914,0591,029,857967,753776,502781,353653,648569,679516,2421,007,560789,515668,837728,847676,631640,025564,616709,34600598,000400,000505,000430,000
       Accounts payable 
396,000
359,000
437,000
384,000
0
0
594,632
548,994
650,174
716,215
625,045
441,562
697,472
986,746
1,072,010
677,633
945,339
847,735
947,114
414,879
881,095
940,784
970,092
390,953
980,183
1,001,194
924,954
800,971
955,660
955,660800,971924,9541,001,194980,183390,953970,092940,784881,095414,879947,114847,735945,339677,6331,072,010986,746697,472441,562625,045716,215650,174548,994594,63200384,000437,000359,000396,000
       Other Current Liabilities 
14,000
10,000
44,000
8,000
0
0
341
341
341
341
0
0
0
0
0
0
0
0
36,910
581,404
33,308
27,690
26,156
550,029
57,591
57,894
58,610
82,496
0
082,49658,61057,89457,591550,02926,15627,69033,308581,40436,91000000000341341341341008,00044,00010,00014,000
   > Long-term Liabilities 
0
0
0
0
0
0
85,847
34,795
31,801
33,315
31,460
31,373
32,267
146,880
333,304
319,659
334,050
340,134
351,319
127,889
287,274
282,565
276,766
186,497
172,583
172,021
158,294
185,177
153,888
153,888185,177158,294172,021172,583186,497276,766282,565287,274127,889351,319340,134334,050319,659333,304146,88032,26731,37331,46033,31531,80134,79585,847000000
       Long term Debt Total 
0
0
0
0
8,299
8,629
5,281
2,441
3,355
0
2,380
927
695
116,933
294,420
285,611
299,839
303,529
313,857
194,665
225,662
222,933
0
0
0
0
0
0
0
0000000222,933225,662194,665313,857303,529299,839285,611294,420116,9336959272,38003,3552,4415,2818,6298,2990000
       Capital Lease Obligations 
0
0
0
0
0
0
14,844
4,263
5,458
4,856
4,446
2,913
2,395
2,854
2,417
2,192
1,943
7,288
11,537
10,673
10,139
8,604
7,408
5,711
4,239
2,850
6,090
7,661
6,190
6,1907,6616,0902,8504,2395,7117,4088,60410,13910,67311,5377,2881,9432,1922,4172,8542,3952,9134,4464,8565,4584,26314,844000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,462
31,224
0
59,632
0
0
0
0
0
0
0
000000059,632031,22437,462000000000000000000
> Total Stockholder Equity
0
0
0
0
528,973
520,775
515,953
337,851
349,975
358,022
345,559
337,528
356,723
358,064
391,840
450,462
414,144
406,504
411,161
-369,694
-142,768
-137,972
-263,671
-299,066
-272,109
-272,998
-174,918
-171,275
-144,078
-144,078-171,275-174,918-272,998-272,109-299,066-263,671-137,972-142,768-369,694411,161406,504414,144450,462391,840358,064356,723337,528345,559358,022349,975337,851515,953520,775528,9730000
   Common Stock
141,000
141,000
141,000
141,000
149,401
151,879
151,879
151,879
151,879
153,339
153,339
153,339
153,339
154,051
154,051
154,051
154,051
154,051
154,051
154,189
154,189
154,189
200,046
200,046
200,046
200,046
200,046
200,046
0
0200,046200,046200,046200,046200,046200,046154,189154,189154,189154,051154,051154,051154,051154,051154,051153,339153,339153,339153,339151,879151,879151,879151,879149,401141,000141,000141,000141,000
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,134
1,343
104,581
105,726
104,461
104,307
105,618
101,867
0
0
0
000101,867105,618104,307104,461105,726104,5811,3439,134000000000000000000
   Capital Surplus 
0
0
0
0
8,657
7,543
6,693
7,191
7,689
3,333
3,440
1,996
2,104
0
403
1,670
2,672
3,674
4,008
3,624
3,624
3,624
0
0
0
0
0
0
0
00000003,6243,6243,6244,0083,6742,6721,67040302,1041,9963,4403,3337,6897,1916,6937,5438,6570000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
414
2,541
3,264
3,289
-7,484
6,020
-1,450
452
-1,277
-954
2,233
1,016
1,460
2,576
9,134
0
235
105,726
104,461
104,307
105,618
0
98,915
100,091
0
0100,09198,9150105,618104,307104,461105,72623509,1342,5761,4601,0162,233-954-1,277452-1,4506,020-7,4843,2893,2642,5414140000



6.3. Balance Sheets

Currency in MYR. All numbers in thousands.




6.4. Cash Flows

Currency in MYR. All numbers in thousands.




6.5. Income Statements

Currency in MYR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in MYR. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,759,479
Cost of Revenue-3,218,985
Gross Profit540,494540,494
 
Operating Income (+$)
Gross Profit540,494
Operating Expense-279,568
Operating Income260,926260,926
 
Operating Expense (+$)
Research Development-
Selling General Administrative279,568
Selling And Marketing Expenses-
Operating Expense279,568279,568
 
Net Interest Income (+$)
Interest Income2,252
Interest Expense-71,969
Other Finance Cost-0
Net Interest Income-69,717
 
Pretax Income (+$)
Operating Income260,926
Net Interest Income-69,717
Other Non-Operating Income Expenses-
Income Before Tax (EBT)194,180327,672
EBIT - interestExpense = -71,969
192,208
203,791
Interest Expense71,969
Earnings Before Interest and Taxes (EBIT)-266,149
Earnings Before Interest and Taxes (EBITDA)266,149
 
After tax Income (+$)
Income Before Tax194,180
Tax Provision-60,386
Net Income From Continuing Ops133,794133,794
Net Income131,822
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,498,553
Total Other Income/Expenses Net-66,74669,717
 

Technical Analysis of Pharmaniaga
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmaniaga. The general trend of Pharmaniaga is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmaniaga's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Pharmaniaga Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharmaniaga Bhd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.175 < 0.18427213114754 < 0.18725538461539.

The bearish price targets are: 0.1605 > 0.13 > 0.1277847826087.

Know someone who trades $7081? Share this with them.๐Ÿ‘‡

Pharmaniaga Bhd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharmaniaga Bhd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharmaniaga Bhd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharmaniaga Bhd. The current macd is 0.00200378.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pharmaniaga price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pharmaniaga. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pharmaniaga price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Pharmaniaga Bhd Daily Moving Average Convergence/Divergence (MACD) ChartPharmaniaga Bhd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharmaniaga Bhd. The current adx is 20.72.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharmaniaga shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Pharmaniaga Bhd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharmaniaga Bhd. The current sar is 0.13483104.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Pharmaniaga Bhd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharmaniaga Bhd. The current rsi is 61.35. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Pharmaniaga Bhd Daily Relative Strength Index (RSI) ChartPharmaniaga Bhd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharmaniaga Bhd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pharmaniaga price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Pharmaniaga Bhd Daily Stochastic Oscillator ChartPharmaniaga Bhd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharmaniaga Bhd. The current cci is 157.02.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Pharmaniaga Bhd Daily Commodity Channel Index (CCI) ChartPharmaniaga Bhd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharmaniaga Bhd. The current cmo is 33.80.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Pharmaniaga Bhd Daily Chande Momentum Oscillator (CMO) ChartPharmaniaga Bhd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharmaniaga Bhd. The current willr is -22.22222222.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pharmaniaga is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pharmaniaga Bhd Daily Williams %R ChartPharmaniaga Bhd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharmaniaga Bhd. The current atr is 0.01149426.

Pharmaniaga Bhd Daily Average True Range (ATR) ChartPharmaniaga Bhd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharmaniaga Bhd. The current obv is 65,269,210.

Pharmaniaga Bhd Daily On-Balance Volume (OBV) ChartPharmaniaga Bhd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharmaniaga Bhd. The current mfi is 74.31.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Pharmaniaga Bhd Daily Money Flow Index (MFI) ChartPharmaniaga Bhd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharmaniaga Bhd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Pharmaniaga Bhd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharmaniaga Bhd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.345
Ma 20Greater thanMa 500.145
Ma 50Greater thanMa 1000.153
Ma 100Greater thanMa 2000.148
OpenGreater thanClose0.155
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pharmaniaga with someone you think should read this too:
  • Are you bullish or bearish on Pharmaniaga? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmaniaga? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharmaniaga Bhd

I send you an email if I find something interesting about Pharmaniaga Bhd.


Comments

How you think about this?

Leave a comment

Stay informed about Pharmaniaga Bhd.

Receive notifications about Pharmaniaga Bhd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.